Vice President, Rare Diseases & Pediatrics
Angi Robinson has been conducting pediatric and rare disease studies at Premier Research for more than 14 years. She has provided oversight and full management support for over 30 rare disease studies, including multiple US and global programs. She has also supported FDA Pre-IND meetings, IND submissions and NDA/BLA project directorship.
“There is nothing more rewarding than giving a child the hope of a long and healthy life, especially when we’re working on new therapies for one of the many rare diseases that currently have no good treatment options.”
Ms. Robinson helped launch the first Best Pharmaceuticals for Children Act – Coordinating Center, collaborating with leadership staff at NICHD. She served as the Project Manager for highly complex trials including pediatric sedation in the PICU and pediatric bipolar disorder. Ms. Robinson’s experience includes multiple study designs including PK/PD, adaptive design and FDA fast track and Breakthrough therapy designations. She has also directed several studies requiring the oversight of data safety monitoring boards and data monitoring committees.
Ms. Robinson began her career in quality control in a laboratory setting and has since worked within clinical trial management as a Project Director/Manager, Clinical Lead, and Clinical Monitor. Ms. Robinson earned a BS degree in Cell and Molecular Biology from Tulane University, New Orleans, LA.